Skip to main content
Silo Wellness Inc. logo

Silo Wellness Inc. — Investor Relations & Filings

Ticker · SILO ISIN · CA8271242072 LEI · 894500CH4X2P5Z2Z5F21 CSE Human health and social work activities
Open in API
Filings indexed 200 across all filing types
Latest filing 2021-08-19 Capital/Financing Update
Country CA Canada
Listing CSE SILO

About Silo Wellness Inc.

https://silowellness.com/

Silo Wellness Inc. is a growth-oriented holding company focused on psychedelic and functional mushroom opportunities, dedicated to expanding psychedelic awareness and providing accessible healing options. The company's core business involves operating psilocybin wellness retreats, primarily located in Jamaica. These retreats utilize evidence-based methods, precise dosing, and professional support, emphasizing individual autonomy and integration for personal exploration and trauma reduction. Silo Wellness is also engaged in intellectual property development, holding the patent-pending status for a psilocybin nasal spray delivery system, which aims to enhance wellness through psychedelics and functional foods. The company positions itself as a trusted leader in psychedelic healing, education, and training.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a $3 million U.S. sales and distribution partnership for Silo Wellness' Marley One line of functional mushrooms. It also includes a corporate update about a loan agreement, debt settlement, issuance of shares for services, and a resignation of a vice president. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content focuses on business updates, financing activities (loan and shares issuance), and management changes. The primary focus is on financing and capital structure updates (loan agreement, shares issued for debt and services). Therefore, the document best fits the category of Capital/Financing Update (CAP).
2021-08-19 English
News release - English.pdf
Regulatory Filings
2021-08-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a private placement financing by LaSalle Exploration Corp. It details the terms of the offering, the investors involved, and the intended use of proceeds. There are no financial statements, quarterly or annual results, or detailed financial analysis included. The document is focused on capital raising activity and financing updates. It is not an annual report, earnings release, or regulatory filing of financial results. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is about 5500 characters, which is consistent with a typical announcement rather than a full report.
2021-07-13 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification form titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS' by the CEO of SILO WELLNESS INC. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended April 30, 2021. The text explicitly states it is a certification of interim filings and does not contain the actual financial data or detailed financial statements. It is primarily an officer certification letter confirming the accuracy and completeness of the interim filings. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2981 characters), consistent with a certification letter rather than a full report.
2021-06-30 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of SILO WELLNESS INC. regarding the interim financial report and interim MD&A for the period ended April 30, 2021. It is a Venture Issuer Basic Certificate under Form 52-109FV2, which is a certification of the accuracy and fair presentation of interim filings. The document does not contain actual financial data or substantive financial analysis but is an attestation letter. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2974 characters), and it is clearly a certification rather than the report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2021-06-30 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis for the three and six months ended April 30, 2021 and 2020' and contains detailed discussion of financial position, results, going concern assumptions, and operational overview for the specified interim periods. It references unaudited condensed interim consolidated financial statements and discusses financial performance and business prospects for a period shorter than a full fiscal year. The content aligns with a comprehensive interim or quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2021
2021-06-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.